Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cryosite Limited ( (AU:CTE) ) has provided an announcement.
Cryosite Limited has completed the acquisition of a new freehold facility at Adderley Street, which more than doubles its national storage capacity. This expansion is a key part of Cryosite’s growth strategy, addressing increasing client demand and enhancing business continuity by providing additional storage space for sensitive materials. The new facility will enable Cryosite to pursue new revenue streams and expand its service offerings, including clinical trial storage, cryogenic storage, and secondary packaging. Initial works at the new site will be staged to align with client demand, ensuring operational efficiency.
The most recent analyst rating on (AU:CTE) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Cryosite Limited stock, see the AU:CTE Stock Forecast page.
More about Cryosite Limited
Cryosite Limited operates in the storage and logistics industry, focusing on high-quality storage and distribution capabilities for clinical trials and research materials. The company provides services related to investigational therapies, biologicals, cryogenic storage, and medical device storage, with a strong emphasis on temperature-controlled environments.
Average Trading Volume: 5,751
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$55.15M
See more data about CTE stock on TipRanks’ Stock Analysis page.